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Abstract
Most of our gut microbiota live with us in a mutually beneficial life-long  
relationship. The gut microbiota plays a vital role in the host’s overall health through 
its metabolic activities. Human microbiota might be supported by consuming 
friendly bacteria (probiotics) and consuming foods to improve the microbiota 
(prebiotics). During the last two decades, probiotics’ interest has increased with 
rising scientific shreds of evidence of benefits on human health. Hence, they have 
been exploited as various food products, mainly fermented foods. Probiotics as a 
treatment modality may restore normal microbiota and functioning of the gastro-
intestinal (GI) tract. Strong scientific evidence is associating these bacteria with the 
prevention and therapy of various GI disorders. (In light of the ongoing trend of 
probiotics, further research is needed to obtain the perspective of potential appli-
cations for better health. Probiotic applications have been extended from health 
applications to food and agricultural applications. The benefits of probiotics led to 
its applications in probiotic ‘health food’ industries and agricultural sectors.
Keywords: Probiotics, Prebiotics, Food products, Gut microbiome, Benefits
1. Introduction
The human body exists in close relation with numerous structurally and 
functionally diverse microbes inhabiting different parts of the body. The mouth, 
the gastrointestinal tract (GIT), and the vagina are most heavily populated. This 
composition is known as microbiota which is acquired soon after birth [1]. The 
microbiota that is exclusively found in GIT is referred to as ‘Gut microbiota.’ Gut 
microbiota is primarily non-pathogenic and plays a vital role in conferring health 
benefits to the host [2].Through metabolic activities and physiological regulation 
such as resistance to pathogens, improvement of intestinal barrier function, promo-
tion of nutrient absorption, formation of bioactive compounds [2]. It may also 
influence the physiology, biochemistry of the host [3].
The idea that bacteria can confer health benefits to humans was postulated 
100 years ago by Elie Metchnikoff. The ‘probiotic’ word is derived from the Greek 
word, meaning “for life” and has had several different meanings over the years [4]. 
The increase in evidence of the benefits of probiotics and prebiotics, especially in 
health improvement, led to its applications in various food industries. This book 
chapter highlights the significance of gut microbiota and the emergence of probiotic 
concepts to benefit human health. In this chapter, we have made a little attempt to 
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introduce the concept of probiotics and prebiotics, their benefits to humans’ health, 
and their probability of being applicable in various fields.
2. Gut microbiota
The human body harbors a complex ecosystem that includes more than 1000 vari-
ous microorganisms [5, 6]. It means the number of bacteria within the gut is about 
ten times that of eukaryotic cells in the human body. In a healthy animal, the internal 
tissues such as blood, brain, muscle, etc. in a healthy animal are usually free of micro-
organisms. However, the surface tissues, such as skin and mucous membranes, are 
constantly in contact with environmental organisms and become readily colonized by 
various microbial species. The microbiota extends from mouth to anus and into the 
vaginal tract of women. In the healthy host, enteric bacteria colonize the alimentary 
tract soon after birth, and the composition of the intestinal microbiota remains rela-
tively constant [7]. The normal flora of humans consists of a few eukaryotic fungi and 
protists, but bacteria are the most numerous and obvious microbial components of 
the normal flora. The total genomic content of microbiota is referred to as a microbi-
ome that inhabits a specific anatomical site of the body [8]. The mixture of organisms 
regularly found at any anatomical site is referred to as the “normal flora”. However, 
researchers in the field who prefer the term “indigenous microbiota,” which includes 
resident microbiota, transient microbiota, and opportunistic microbiota.
The gut microbiome exhibits various interactions with the human body. It may be 
mutualistic or pathogenic. The interactions between the gut microbiome and host have 
evolved into symbiotic relations. It confers various benefits to the human body, sig-
nificantly strengthens the host’s immune system, and protects against various diseases 
caused by harmful pathogens. Hence, it is helpful to study the symbiotic relationship 
of the gut microbiome with the host and its influence on the host’s overall health.
2.1 Composition of gut microbiota
The gut microbiota is composed of four main phyla: Firmicutes, Bacteroidetes, 
Actinobacteria, and Proteobacteria. Predominantly, anaerobic bacteria colonize the 
Gastrointestinal tract (GIT) [9].
GI tract consists of the stomach, small intestine, and large intestine. Various 
parts of the GI tract differ in their environmental characteristics, chemical compo-
sitions, and physiological properties. Therefore types and numbers of microbiota 
vary in different parts. In general, microorganisms increase in numbers from the 
stomach to the small intestine to the large intestine.
2.1.1 Microbiota of stomach
The microbes in the stomach are primarily of similar types that are present in the 
mouth and throat. Generally, aerobic microbes inhabit the stomach, and that too in 
a lesser amount than the population of mouth and stomach. The stomach receives 
many microbes from the mouth through food and water, but most of them are killed 
due to hydrochloric acid (HCl). Thus, few microorganisms that can tolerate high pH 
can form normal resident flora of the stomach.
Organisms generally found in the stomach are – Lactobacillus, Enterococcus, 
Streptococcus, Staphylococcus, Peptostreptococcus, Candida, Helicobacter pylori, etc. 
[10, 11]. Some of them are hazardous to health, such as Helicobacter pylori, which 
can cause chronic gastritis and peptic ulcers.
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2.1.2 Microbiota of small intestine
The small intestine is a tube about 6 meters long-running from the stomach to 
the large intestine. The small intestine usually has three sections: duodenum, jeju-
num, and ileum. Each section reflects slightly different functions. The microbiota 
of the small bowel is the least well understood due to its inaccessibility for study.
Duodenum is adjacent to the stomach, and it is slightly acidic. The duodenum 
includes similar types of organisms that are found in the stomach. It mainly acquires 
acid-resistant organisms such as Lactobacillus and Enterococcus. The intestine 
becomes less acidic from the duodenum to the ileum; hence, the microbial popula-
tion increases. In the jejunum, prominently, lactobacillus, Enterococci, Candida 
albicans, etc., are found. In ileum microbial population resembles that of the large 
intestine. It mainly includes obligate anaerobes such as Clostridium perfringes, anaer-
obic E. coli., Bacilli, Streptococcaceae. Actinomycinaeae and Corynebacteriaceae are 
abundant in the duodenum, jejunum, or ileum [12, 13].
2.1.3 Microbiota of large intestine
The large intestine follows on from the small intestine. The large intestine 
receives remains of food that enzymes have not digested. The chyme, on entering 
the large intestine, is referred to as feces. The large intestine is divided into three 
distinct parts: caecum, colon, and rectum. About 1100 different species of microbes 
are present in the large intestine [14].
The large intestine harbors obligate anaerobes and facultative anaerobes. The 
more common genera include Bacteroides, Clostridium, Eubacterium, Roseburia, 
Faecalibacterium, and Ruminococcus [15, 16]. The large bowel includes increased 
Lachnospiraceae (Firmicutes) proportions, and Bacteroidetes are found in the colon 
[13]. It also inhibits E.coli, Lactobacillus, Bifidobacterium, Enterococcus in smaller 
numbers.
2.2 Benefits of gut microbiota
Earlier, the gut microbiota was thought to be commensals whose only ben-
efit was controlling the abundance of pathogenic bacteria. However, as the 
knowledge about these symbionts increased, their essential roles, such as aiding 
digestion and various metabolites, were also known to improve the immune 
system [17, 18]. The gut microbiota plays a crucial role in immunomodulation 
and the nervous system and intestinal mucosal system development. In addi-
tion, gut microbiota plays a crucial role in synthesizing essential vitamins such 
as vitamin B12, vitamin K, nicotinic acid, pyridoxine, thiamine [19]. The gut 
microbiota generates short-chain fatty acids (SCFAs) by fermenting complex 
carbohydrates. These SCFAs play a significant role in inflammatory response and 
regulation of immune response. The gut microbiota also influences epithelial 
homeostasis [19].
There are pieces of evidence that gut microbiota provides extra nutrition. It 
could be due to the digestion by enzymes of the resident microbiota. Another 
benefit of gut microbiota is a defense against a range of pathogens, including 
Listeria cytogenes, Clostridium botulinum, and Cryptosporidium parvum. The gut 
microbiota provides a hostile environment, produces antimicrobial substances, and 
strengthens the human body’s defenses to defend against pathogens. It also stimu-
lates peristalsis, so gut contents are moved more quickly, making it more difficult 
for newly-arrived pathogens to be established.
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2.3 Disturbance of gut microbiota
The composition of gut microbiota may vary between individuals though some key 
bacterial species are typically present in most. Diet is thought to explain over 50% of 
these microbial structural variations in mice and 20% in humans, signaling the potential 
for dietary strategies in disease management through gut microbiota modulation [20]. 
The gut microbiota shows drastic changes in infants with lactation followed by an 
introduction to solid food. The mode of intake, medication dosage may influence the gut 
microbiota. Gut microbes are regularly purged and have the ability to double in specific 
time intervals. The short-term and long-term dietary changes and modification in 
micronutrient intake can significantly change gut microbiota composition. The experi-
ment conducted by Wu et al. showed a dramatic shift in the fecal microbiota of the 
participants due to high fat/low fiber and low fat/high fiber. Fiber content and type were 
thought to be primer determinants of the composition of the microbiota of the gut.
Through antibiotics, improvement in human health is achieved through the 
drugs have negative consequences also. Antibiotic drugs control the infections 
caused by pathogens, but other beneficial bacteria are also harmed. A disturbed 
microbiota may not function well against infections caused by new pathogens, 
resulting in the overgrowth of pathogens such as Clostridium difficile [21]. Several 
factors may influence the disturbance of gut microbiota caused by antibiotics:  
(i) the dose and duration of the drug (ii) the range of microbes affected by antibiot-
ics (e.g., broad-spectrum or narrow-spectrum) (iii) the proportion of antibiotic 
that is being absorbed into the body or resides in the intestine.
Most antibiotics are taken orally, and some are given intravenously. The latter 
type has a significant influence to disturb microbiota. Different antibiotics have 
different effects, e.g., penicillin has minor effects on the gut microbiota, while 
ampicillin causes significant disturbance to the gut microbiota. Thus, there is a need 
to develop an alternative that is safer and effective for use. Increasing knowledge of 
probiotics and their efficacy against pathogens can aid the recovery of gut micro-
biota. Probiotics may be suitable to take after or simultaneously as antibiotics to 
reduce the risk of disease from disturbance of microbiota.
3. Probiotics
Probiotics are live organisms which when administered in an adequate amount, 
confers health benefits to the host (FAO and WHO, 2002). The characteristics 
of effective probiotics are their ability to survive the passage through the diges-
tive tract and utilize the nutrients and substrates in a normal diet. Probiotics are 
healthy gut flora and thereby improve digestion. Several criteria have been used to 
prove any strain as novel probiotic strains, categorized into two groups: safety and 
functionality. The concept of probiotics deals with the constant introduction of the 
new microbes beneficial to the human host as an attempt to change the indigenous 
microbial population equilibrium to increase overall health [22].
3.1 History of Probiotics
The concept of using microbes to improve health is a hundred years old. 
During the twentieth century, probiotics gained much interest due to an increase 
in scientific evidence proving the beneficial effects of probiotics. The idea that 
bacteria could benefit human health was postulated almost 100 years ago by Elie 
Metchnikoff while working at the Pasteur Institute in Paris. Metchnikoff ’s adop-
tion of an idea to use beneficial bacteria to improve the bacterial population of 
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the intestine arose from his inquiries into how old age could be delayed and life 
prolonged. Metchnikoff concluded that fermented milk drank by peasants of 
Bulgaria has a key role (Metchnikoff 1907) [21] in their longevity. He found a 
bacterium from peasant’s milk and named it Bacillus bulgaricus. He explained that 
the production of lactic acid by a bacterium reduces the harmful effects of other 
microorganisms. It is not sure which bacterium was found by Metchnikoff. It may 
be Lactobacillus bulgaricus, a strain that is commonly used in yogurt.
The term probiotic literally means ‘for life is derived from the Greek language. 
Lilly and Stillwell first coined this term in 1965 to describe “substances secreted by 
one microorganism which stimulates the growth of another” and thus was con-
trasted with the term antibiotic [23]. Parker modified this definition to “organisms 
which contribute to intestinal microbial balance” [24]. The concept of probiotics 
became weak after the early death of Metchnikoff and the development of antibi-
otic drugs. Though, interest in the general public did not fall entirely. One of the 
factors that gained the popularity of probiotics towards the end of the century is the 
rise of resistant strains of pathogens against different antibiotics.
3.2 Mechanism and action of probiotics
The mechanisms of probiotic action are diverse. The activities of these strains 
can influence other factors such as the presence of other bacteria in the intestinal 
environment or even the disease setting in which the strain is being used [25]. 
The characteristics of effective probiotics are their ability to survive the passage 
through the digestive tract and utilize the nutrients and substrates in a normal diet. 
However, some mechanisms have been reported for most of the probiotic strains, 
which include: colonization resistance, antimicrobial activity, antimutagenic 
effects, antigenotoxic effects, influence on enzyme activity, etc.
The probiotic bacteria have antagonistic effects on different microorganisms 
and competitive adherence to mucosa and epithelium. These characteristics also 
work as antimicrobial activity. By decreasing luminal pH, they are inhibiting other 
bacterial adherence, translocation, and secretion of antimicrobial substances 
such as antimicrobial peptides (e.g., bacteriocin), organic acids (lactic and acetic 
acid), hydrogen peroxide (in environments in which oxygen is present), diacetyl, 
β-hydroxypropionaldehyde [26–30]. The probiotics are also capable to modulate 
cell proliferation and apoptosis. Polysaccharide fermentation by probiotic strains 
increases the availability of short-chain fatty acids (SCFAs), which felicitate repair 
of epithelial damage. Some strains also produce mucus excessively, which enhances 
the intestinal barrier. It can separate bacteria from the lumen and prevent the 
colonization of the epithelium [31]. Probiotics can exert control over epithelial 
cells, dendritic cells, monocytes, macrophages, lymphocytes, IgA through differ-
ent mechanisms for the stimulation of the human immune system; increased IgA 
decreases the number of pathogens, thus improving gut health [32, 33]. Figure 1 
shows various mechanisms by which probiotics benefits health of host.
3.3 Types of probiotic microbes
There is a growing number of microorganisms described as probiotics. Among 
the various types of microbes, bacteria are used as probiotics mainly. The potential 
of intestinal and dairy species Lactobacilli and Bifidobacteria as probiotics was 
postulated over a hundred years ago. At that time, the yearning to understand the 
microbial ecology of these groups in the human intestine was linked to the aspira-
tion to manage and maintain human health. The link between Lactobacilli and 
human health was first proposed in the late 1800s by Metchnikoff [34].
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The majority of the different species included in probiotics belong to the genus 
Lactobacillus. Metchnikoff favored this bacterium. They are normal flora of the 
small bowel as there is a wide range of food in that part of the small intestine. There 
are fewer lactobacilli present in the large bowel also. Lactobacilli are easy to grow, 
which aid as an essential factor in using probiotics at a commercial scale. Other 
characteristics of lactobacilli are resistance to gastric stress and the ability to grow in 
a microaerophilic environment that makes them well-suited to live in the gastroin-
testinal tract. Lactobacilli are heterofermentative and require many micronutrients 
to grow. The species most commonly used in probiotics are L. acidophilus, L. casei, 
L. crispatus, L. johnsonii, L. plantarum, L. reuteri, L. rhamnosus, L. salivarius. The 
probiotic effect of lactobacilli is as follow:
• Secretion of lactic acid lowers the pH of GIT and eliminates harmful bacteria. 
Some lactobacilli produce acetic acid, which gives a more substantial effect 
than lactic acid against pathogens.
• Lactobacilli produce antibiotic-like compounds referred to as bacteriocins, 
which restrict the growth of pathogens. Some of them also produce hydrogen, 
which exerts antibacterial effects.
• Lactobacilli tend to attach to mucosa and form colonies, which is the primary 
requirement of good probiotics. They block the attachment of pathogens and 
may also influence the immune cells in the gut wall. Some lactobacilli also 
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There are other genera of lactic acid-secreting bacteria. One of them is 
Enterococcus, which has species such as E. faecium that are used as probiotics. The 
mechanism is similar to those of lactobacilli.
Bifidobacteria are the second most commonly used type of bacteria in probiotic 
products. One of the reasons for their less popularity could be their incapability 
to grow and process commercially. Henry Tissier identified the unusually shaped 
Bifidobacterium from the stool of the baby. A large number of these bacteria in the 
intestine of the baby reassured that they are probably beneficial. Bifidobacteria 
reduce lactose intolerance, cholesterol levels, improve the gut immune system, and 
prevent gut infection in infants. Some of the species frequently used in probiotics 
are Bif. adolescentis, Bif. animals, Bif. bifidium, Bif. breve, Bif. longum, and Bif. infantis.
Like lactobacilli and bifidobacteria, other organisms such as E. coli, Bacillus 
subtilis, Saccharomyces cerevisiae, S. boulardii. Most E. coli are benign commensals, 
but some are opportunistic pathogens. E. coli Nissle 1971 (EcN) is the best known 
E. coli probiotic [35, 36]. Nissle bacteria are protected from stomach acid by added 
enteric coating. The coating won’t dissolve until it reaches the ileum and caecum. 
EcN strengthens the barrier function of epithelial cells against pathogens. EcN 
has been used as an anti-diarrhoeal and to treat constipation and ulcerative colitis 
[21]. Bacillus subtilis is a spore-forming bacterium; the spores protect the cells from 
gastric acid. Some of the spores germinate in the intestine and influence the gut 
immune system and stimulate lactobacilli’s growth. Some other Bacillus species 
are used as probiotics, such as B. coagulance, B. licheniformis, B. pumilus, and B. 
clausii. Saccharomyces boulardii, a sub-species of S. cerevisiae is used as probiotics. 
S. boulardiiis not normal flora of the gut, but it can live there temporarily and gives 
anti-diarrhoeal effects. Some probiotic organisms with Generally Regarded As Safe 
(GRAS) status are listed in Table 1.
4. Benefits of probiotics
There are certain diseases related to the disturbance of microbiota of the gas-
trointestinal tract. Some of them are infectious diarrhea, irritable bowel syndrome 
(IBS), inflammatory bowel disease (IBD), lactose intolerance, antibiotic-associated 
diarrhea, constipation, gastritis, and stomach ulcers. There are evidences available 
showing influence of probiotics to treat such diseases. Other body parts may benefit 
Probiotic Lactic acid bacteria
Lactobacillus spp. Bifidobacterium spp.
Lactobacillus rhamnosus Bifidobacterium lactis
Lactobacillus plantarum Bifidobacterium bifidum
Lactobacillusreuteri Bifidobacterium animalis
Lactobacillus acidophilus Bifidobacterium breve
Lactobacillus casei Bifidobacterium infantis
Bifidobacterium longum
Other lactic acid bacteria Non-lactic acid bacteria and yeast
Lactococcus lactis Propionibacterium freudenreichii
Streptococcus thermophilus Saccharomyces cerevisiae
Table 1. 
List of probiotic microorganisms [21, 37–39].
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from probiotics as microbiota is present in other body parts, not just the intestine. 
Furthermore, the immune system is connected to all parts of the body, so by influ-
encing one part of the immune system, probiotics may influence others.
4.1 Effect of probiotics on diarrhea
Infectious diarrhea, traveler’s diarrhea (TD), antibiotic-associated diarrhea 
are various types of diarrhea caused by different conditions. Infectious diarrhea is 
generally caused by pathogenic microbes such as viruses, bacteria, yeast, or proto-
zoan. Generally, normal bowel movements return after about three days, but they 
may not in children with acute diarrhea. In infants, rotavirus is the most common 
microbe responsible for diarrhea. Probiotics have been tried in many clinical stud-
ies as a supplement for rehydration therapy to treat infectious diarrhea in infants. 
The results have been positive and consistent [40]. In young children, the probiot-
ics were also found to be effective in preventing the development of infectious 
diarrhea. The types of probiotic microbes used are lactobacilli, bifidobacteria, S. 
boulardii (yeast).
The traveler’s diarrhea may be caused by the water supply being contaminated 
with fecal matter, contaminated food. In the case of traveler’s diarrhea, the use of 
probiotics is more likely to be considered by adults. Though, the use of probiotics 
in TD has given a mixed response as the cause of TD differs depending on the local 
situation [41].
The use of antibiotics has revolutionized the treatment of bacterial infections. 
However, it promotes the rise of resistant bacteria and disturbs gut microbiota’s 
composition, which makes us vulnerable to pathogenic infection. Such infection of 
the intestine leads to diarrhea, referred to as ‘antibiotic-associated diarrhea (AAD)’. 
When the gut microbiota is disturbed, Clostridium difficile increases to infection 
level; this bacterium causes about one-fifth of AAD. In several studies, probiotic 
yeast S. boulardii was effective against C. difficile when given along with antibiotics 
[42]. In a number of cases, probiotic microbes such as LAB, S. boulardii, Clostridium 
butyricum prevented such diarrhea, although not all studies have shown probiotics 
to be effective [42–45].
4.2 Effect of probiotics in Irritable Bowel Syndrome (IBS)
The irritable bowel syndrome is a common gastrointestinal disorder. In IBS an 
abnormal condition of gut contractions (motility) and increased gut sensations 
(visceral hypersensitivity) characterized by abdominal pain/discomfort, gas, 
bloating, mucous in stools, and irregular bowel habits with constipation or diar-
rhea. Several studies show the effect of probiotics on this disease; however, the 
mechanism by which probiotic organisms affect this condition is still unknown. A 
review and meta-analysis by Ford et al. concluded the beneficial effects of probiot-
ics as a treatment on IBS symptoms, including RCTs published between 1939 and 
2013, and it was emphasized that multi-strain probiotics had a more distinct effect 
on IBS symptoms [46, 47]. However, Lactobacillaceae and Bifidobacteriaceae (genus: 
Lactobacillus and Bifidobacterium) were the two most common families used in 
multi-strain probiotic supplements [47].
4.3 Effect of probiotics in inflammatory bowel disease (IBD)
Inflammatory bowel disease is a group of the chronic intestinal disease charac-
terized by inflammation of the large or small intestine. Crohn’s disease (CD) and 
ulcerative colitis (UC) are the most common types of IBD. UC only affects the large 
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bowel, and the inflammation is usually found in the rectum and the sigmoid colon 
but can be found anywhere along with the large bowel. CD can affect any part of 
the digestive tube from mouth to the anus but is most often found in the area of the 
junction of the ileum and caecum. The evidence of benefit from probiotics in UC 
is strong, while the evidence in Crohn’s is weak. There have been eight controlled 
trials involving people with UC in one study, and seven of them showed significant 
benefit from probiotics. Use of probiotics extended periods of remission or reduced 
active disease [48]. Some studies have been conducted with E. coli Nissle (EcN), 
Saccharomyces boulardii. These microbes have been reported to have some beneficial 
effects in IBD [41, 49]. E. coli probiotic was found to be as effective as a standard 
drug used in UC to prevent relapse. In comparison, only a small number of trials 
showed the benefit of probiotic yeast S. boulardii in Crohn’s disease.
4.4 Effect of probiotics in lactose intolerance
The inability of some adults to digest the sugar lactose, which is present in milk, 
is referred to as ‘lactose intolerance. The lactose is hydrolyzed by the enzyme lac-
tase, which is also known as lactose- galactosehydrolase (EC 3.2.1.108). The lactose 
is digested into glucose and galactose, which is taken up by intestinal cells and 
transported to the bloodstream. The remaining lactose, which is not hydrolyzed, 
passes to the colon [36]. The person with lactose intolerance produces less lactase, 
which is inefficient in digesting much of the milk sugar. The undigested lactose 
causes intestinal difficulties. When lactose intolerant people consume milk, they 
may suffer from excess gas, diarrhea, cramps, bloating, abdominal rumblings, and 
flatulence. One of the reasons for excess gas could be the fermentation of glucose 
by gut microbiota. As lactose is an active osmotic compound, it causes osmotic 
pressure, leading to high water content in the feces, causing clinical symptoms as 
diarrhea [36]. Probiotics have gained attention as an alternative to compensate for 
the low level of lactase [41, 50]. Probiotic can affect at two levels: (i) By increasing 
hydrolytic activity in the small intestine (ii) By increasing colonic fermentation 
[51]. Several studies have shown the effect of probiotic yogurt in better lactose 
digestion in lactose-intolerant people. The probiotic bacteria used in yogurt 
(Lactobacillus bulgaricus and Streptococcus thermophilus) produce a significant 
amount of their own lactase. Evidence suggests that probiotic organisms can digest 
lactose in yogurt products and continue digestion in the small intestine when con-
sumed [52]. They prevent excess gas production and reduce or eliminate diarrhea. 
The yogurt allows more time for lactase to digest lactose as yogurt has a thicker con-
sistency; it takes a longer time to pass through the intestine. There is some evidence 
showing that Russian fermented milk- kefir or variants of kefir (sugary kefirs, kefir 
grains) effectively alleviate lactose intolerance [53]. There are probiotic products 
available in capsule, tablet, or powder form (e.g., Lactobacillus and Bifidobacterium 
species used in non-milk products); however, they do not appear to be as effective 
as yogurt.
4.5 Effect of probiotics in gastritis and stomach ulcers
A bacterium, Helicobacter pylori, causes inflammation of the mucosal barrier of 
the stomach. As well as frequent long-term use of nonsteroidal anti-inflammatory 
drugs is the major factor involved in gastric ulcer development [53]. Gastric muco-
sal damage is common; if not treated adequately, it may lead to gastric cancer. To 
eradicate H. pylori, three drugs are used simultaneously: two antibiotics and a pro-
ton pump inhibitor [54]. However, this treatment fails in most of the cases due to 
antibiotic-resistant strains of H. pylori; thus, a fourth antibiotic is added to standard 
Prebiotics and Probiotics - From Food to Health
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triple therapy used previously. The therapy may cause side effects such as diarrhea, 
taste disturbance, and nausea.
The growing interest in probiotics to prevent or treat gastrointestinal diseases 
has attracted the attention of many researchers to explore the role of probiotics 
in the prevention and treatment of gastric ulcers [50]. Some studies have found 
out that when probiotics are used in conjunction with standard drugs, the rate of 
eradication was higher than drug therapy or probiotics alone  [55]. However, side 
effects caused by drug therapy were reduced by probiotics. Most of the studies have 
used lactobacilli, but not all strains showed effects against H. pylori. Probiotic yeasts 
S. boulardii also showed potential therapeutic effects in gastric ulcers. S. boulardii 
acquires neuraminidase activity which removes sialic acid, which results in the 
prevention of binding of H. pylori to epithelial cells [53].
4.6 Effect of probiotic in vaginal infections
In a healthy woman, the vagina has a resident microbial population. These 
resident microbiota live on the lining of the vagina wall. Most of them are lactoba-
cilli. The vaginal lactobacilli have a protective influence against urogenital infec-
tions [50]. The vaginal infections are referred to as vaginitis. In which pathogenic 
infections cause inflammation of the vaginal lining. If a bacterium causes vaginitis, 
it is known as bacterial vaginosis (BV). If vaginitis is caused by a fungus (generally 
Candida- a type of fungus), it is known as vaginal candidiasis (VC). Both types of 
vaginitis symptoms are similar, such as burning sensation during urination, itching 
in the vaginal area, and greyish or white discharge. Antibiotics or antifungals treat 
the infection. There is evidence that some women have H2O2 – secreting lactobacilli 
in their intestine, which lowers the risk of BV. This suggests that the rectum act as a 
reservoir supplement vaginal microbiota when it becomes disturbed. This informa-
tion leads to the development of probiotics to protect the female reproductive sys-
tem [56, 57]. Though studies have shown mixed responses. In the case of VC, a small 
number of clinical studies have been undertaken of probiotics against Candida. In 
most of the studies, probiotics didn’t show any significant effect. However, when 
probiotics were taken along with antifungal drugs, they improved the effectiveness 
of antifungal significantly [58].
4.7 Effect of probiotics in upper respiratory infections
The upper respiratory tract (URT) consists of the nose, throat, and windpipe. 
The nose and throat have microbiota, and the upper part of the windpipe has a 
changing microbial population as cilia move mucus upward to the throat. The 
various diseases associated with URT are common cold, sore throat, pharyngitis, 
epiglottitis, laryngitis, and diphtheria [29]. Most commonly, viruses such as 
rhinoviruses, coronaviruses, parainfluenza, and influenza viruses and bacteria such 
as streptococci, Mycoplasma pneumoniae, Chlamydia pneumoniae, Corynebacterium 
diphtheria, Staphylococcus aureus, Haemophilus influenzae type b, Streptococcus 
pyrogens, and Streptococcus pneumonia are associated with URT infection [59, 60]. 
Infection of URT may spread to the lungs, causing bronchitis and pneumonia. Some 
studies have shown that probiotics may reduce the severity and duration of the 
condition. Some probiotic bacteria such as Lactobacillus rhamnosus, Streptococcus 
thermophilus, Bifidobacterium animals were beneficial to reduce and prevent URT 
risks in children and adults [29]. Probiotics may also improve the effectiveness of 
influenza vaccination in the elderly. This improved immune reaction may enhance 
protection against acquiring influenza, although it is yet to be confirmed.
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4.8 Effect of probiotics in constipation
Constipation is quite a common condition that can be acute or chronic. 
Constipation causes a general feeling of abdominal discomfort. To pass the stool 
straining may put pressure on the tissues and structures of the anal area with 
adverse consequences such as hemorrhoids (piles). Other diseases associated with 
constipation are irritable bowel syndrome and cancer of the large bowel. Several 
studies have been conducted using Lactobacillus rhamnosus, Lactobacillus casei, 
Bifidobacterium animalis, and probiotic E. coli. [61, 62]. Prebiotics also may be 
effective against constipation as FOS, GOS, and lactulose have mild laxative effects 
[63]. These laxative effects can be due to osmosis as prebiotics are soluble fibers. 
Prebiotics also boost bifidobacteria and lactobacilli, and these probiotic bacteria 
accelerate the transit of large bowel content. However, meta-analyses also indicate 
that groups of probiotics and synbiotics have more efficiency than individual 
probiotics [64].
4.9 Other benefits
The list of benefits of probiotics is not limited to the ones mentioned above. 
However, it includes a range of benefits that need to be explored for further human 
studies. Some evidences suggest that probiotics may influence cancer incidence 
[50]. As well as researchers are exploring various alternatives of drugs from probi-
otics that can be used to treat a disease like cancer and with lesser or no side effects. 
(i.e., L-asparaginase that is used in cancer treatment from L. casei, L. reuteri, etc. 
is being explored) [43, 65]. Furthermore, evidences suggests that food products 
with probiotic organisms may reduce serum cholesterol levels and control blood 
pressure. Probiotics may also prevent coronary heart disease [66, 67]. Several 
studies examined the effect of probiotics and prebiotics to treat allergic conditions. 
However, studies to prevent allergic conditions like asthma and allergic rhinitis 
did not show a positive response. However, studies examined that when pregnant 
women have probiotic intake, it improves the functioning of the mother’s immune 
system and indirectly improves the immature immune system of the infant, reduc-
ing the risk of allergies such as eczema and dermatitis [68]. But there are insuf-
ficient evidences to recommend probiotics as standard therapy to prevent allergies 
[44]. There is a close relationship between microbiota and the immune system of 
the skin. Consumption of probiotics has provided some protection against ultra-
violet radiation from the sun. Vitreoscilla filiformis showed a beneficial effect on a 
patient with seborrhoeic dermatitis and atopic eczema [69]. As described earlier, 
LAB, especially lactobacilli and bifidobacteria, exert a beneficial effect in infants 
with atopic eczema. A prebiotic cream has been developed with encouraging results 
in controlling acne-associated organism Propionibacterium acne. However, much 
more exploration and research are needed to use probiotics routinely for the skin.
5. Application of probiotics
Due to the health benefits exerted by probiotic organisms, they have a wide 
range of applications in clinical uses and various industries such as food industries 
and agriculture industries. Most species of lactobacilli and bifidobacteria are used 
commercially. Among them L. rhamnosus, L. plantarum, L. casei, L.paracasei, B. 
animalis are widely used. With that in some products organism such as S. thermophi-
lus is used.
Prebiotics and Probiotics - From Food to Health
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5.1 Application of probiotics in the food industry
Increasing knowledge of probiotic benefits leads to the development of func-
tional foods. Functional foods, also known as “nutraceuticals” or “designer foods,” 
are ingredients that offer health benefits that extend beyond their nutritional 
value. Some types contain supplements or other additional ingredients designed 
to improve health, and they are slowly emerging as ‘health food’ on supermarket 
shelves worldwide [70]. A wide variety of dairy products such as milk, yogurt, 
cheese, ice cream, chocolate mousse, quark, etc., include probiotic organisms to 
improve their nutrition characteristics [70–74]. Furthermore, whey-based and 
fortified dairy beverages are also available, including probiotic and prebiotic.  
L. rhamnosus GG is widely used in such beverages [75, 76]. The development of non-
dairy-based products has gained attention in developed countries as a population 
Food product Probiotic organism used References
Acidophilus milk Lactobacillus acidophilus [79]




















Yosa (oat-bran pudding) Lactobacillus acidophilus [80]
Uji Lactobacillus paracasei [80]






Kombucha (Fermented tea 
beverage)
Saccharomyces cerevisiae [80]
Kimchi (Fermented vegetable 
dish)
Lactobacillus sakei, Lactobacillus Plantarum,
Lactobacillus curvatus,
[80]







Bulgarian boza Lactobacillus coryniformis [35]





List of probiotic food products.
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with vegetarianism and lactose intolerance is higher [77]. Non-dairy based product 
includes fermented vegetable and fruit-based probiotics. Other non-dairy products 
such as cereal, soy, and meat-based probiotics such as fermented oats, sourdoughs, 
sausages, fish are available [78]. Probiotic organisms and substances secreted by 
them are used to preserve and enhance the quality of food. Various probiotic food 
products are listed in Table 2.
5.2 Application of probiotics in agriculture
Other than human, probiotics application is extended to agriculture as well. One 
of them is probiotic farming, which is referred to as bio-intensive agriculture that 
combines various organic farming techniques to make soil healthier. It introduces 
beneficial microorganisms into the growing environment. The use of probiotics 
increases crop yield, limits the need for harmful fertilizers and pesticides and 
depletes damages caused by them. Probiotics also amplify plant’s resistance to 
pests and diseases. Due to antagonistic effects exhibited by probiotic bacteria by 
‘induced systemic resistance,’ plants are protected from pathogenic microorgan-
isms. Bacillus spp., LAB, Actinomycetous, etc. Protect plants from cropping hazards. 
Furthermore, plant probiotic microorganisms (PPM) can influence the synthesis of 
phytohormones and their balance in plants. Some commercial plant products that 
use probiotic cultures are Kodiak (Bacillus subtilis GB03), YiedShield (B. pumilis 
GB34), Rotex (Phlebiopsisgigantea) [21]. Probiotics used in animal feed supple-
ments advantageously alter gastrointestinal flora and improve host animals’ health 
and productivity. Probiotic solely or in combination with prebiotic improves the 
pattern of microbial population in GIT and benefits host’s health [86]. Probiotic is 
generously applied in poultry and aquaculture. Some feed additives can modulate 
the intestinal milieu and exert beneficial substances in the intestine [87]. Probiotics 
gained attention to use as an alternative to antibiotics in poultry to get the product 
with quality and safety [88]. It also reduces their mortality rate and increases bone 
quality. In ruminants, probiotics increase forage intake, increasing fiber digestion 
rate, which results in improved weight gain, milk yield, and milk fat content [86]. 
Probiotic also decreases the prevalence of coliform infection in pre-ruminant calves. 
The use of probiotics in aquaculture prevents the adhesion of pathogens from fish-
ing intestinal mucus.
5.3 Application of probiotics in clinical use
As described earlier, probiotics prevent or mitigate various diseases and severe 
symptoms by various mechanisms, but it is advisable to take care when used in 
immune-compromised patients. Encouraging evidences are emerging for pro-
biotics’ efficiency in the management of pouchitis and pediatric atopic diseases. 
Probiotics are also helpful in preventing postoperative infections [89]. There is 
strong evidence that some bacterial strains are efficient in enhancing immune 
function. Probiotics are also beneficial in mental disorders and reduce carcinogenic 
activity, cholesterol level, and blood pressure [35]. The significance of probiotics in 
preventing traveler’s diarrhea, sepsis-associated with severe pancreatitis, ulcerative 
colitis, and reduction of hyper cholesterol is unproven [89, 90]. The chemothera-
peutic drugs such as L-asparaginase with fewer side effects from probiotic bacteria 
are still being explored. A study reported the use of kimchi to treat cancer [21]. 
Furthermore, the development of alternative antibiotics such as lantibiotics, 
antimicrobial peptides (AMPs) from probiotic bacteria are being explored to reduce 
side effects caused by traditional drug therapies and as a next-generation drug 
system against resistant pathogens. LAB bacteriocin- Nisin is commercially used 
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as a food preservative [35]. It also has biomedical applications as it exhibits anti-
microbial activity against resistant pathogens and anti-biofilm properties to use in 
combination with therapeutic drugs [91]. Although probiotics have shown encour-
aging evidence of efficacy in various diseases, there is much exploration needed for 
standard clinical practice in humans.
6. Conclusion
Exploration of gut microbiota indicates that beneficial gut microbiota plays 
a crucial and constructive role in maintaining the health of host (human). The 
symbiotic relation of gut microbiota with host and benefits exhibited by them leads 
to the development of probiotics and prebiotics. Studies on various mechanisms 
of probiotics have shown their abilities to prevent or treat various diseases in 
human. Due to this efficiency, probiotics and prebiotics and their applications in 
various fields have shown a substantial increase in the last two decades. Probiotics 
are mainly applied in the food industry to develop functional foods and supple-
ments to benefit consumers. The applications of probiotics are also extended to the 
agriculture industry to boost the productivity and quality of crops and animals. The 
emergence of encouraging evidence has given a sight to use probiotics in clinical 
practices with minimum side effects. However, clinical use of probiotics as standard 
practice is under the umbrella of research yet.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
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